Company Asterias Biotherapeutics Inc OTC Bulletin Board
Equities
US04624N1072
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 19-03-07 |
Munish Mehra
PRN | Corporate Officer/Principal | - | - |
George Samuel
SEC | Corporate Secretary | 43 | - |
Frank Lanza
AUD | Comptroller/Controller/Auditor | 62 | 15-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,658,684 | 54,849,986 ( 98.55 %) | 0 | 98.55 % |
Company contact information
Asterias Biotherapeutics, Inc.
2173 Salk Avenue Suite 200
92008, Carlsbad
+510 456 3800
http://asteriasbiotherapeutics.com/![address Asterias Biotherapeutics Inc](https://cdn.zonebourse.com/static/address/16917640.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.66% | 53.67B | |
+33.67% | 38.86B | |
-7.81% | 38.76B | |
-10.77% | 27.27B | |
+11.77% | 25.91B | |
-17.82% | 20.29B | |
+35.09% | 12.78B | |
+29.17% | 12.18B | |
-3.05% | 11.96B |
- Stock Market
- Equities
- AST Stock
- Stock
- Company Asterias Biotherapeutics Inc